Geneoscopy
Geneoscopy is a non-invasive colorectal cancer diagnostic powered by advanced research in computational biology. The company is determined to replace every patient’s least favorite screen: the colonoscopy. Currently, there is no test with high enough specificity and sensitivity to allow patients an alternative to the unpleasant, invasive colonoscopy. Geneoscopy is changing that. It has developed a novel methodology to reliably and consistently extract human RNA transcripts from stool samples and detect changes in gene expression. This provides Geneoscopy a platform to harness the power of RNA to detect, prevent, and guide treatment for gastrointestinal disease. Geneoscopy is currently developing a diagnostic test for the prevention of colorectal cancer and is conducting research on other applications of its technology for tangential indications.
Domain
geneoscopy.com
Country
United StatesIndustry
BiotechnologyEmployees
51-100
Last Funding
$105.0M
Founded
2015
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Geneoscopy use?+
Geneoscopy uses 17 technologies including Google Analytics, Google Tag Manager, WordPress.
What industry is Geneoscopy in?+
Geneoscopy operates in the Biotechnology industry.
Where is Geneoscopy based?+
Geneoscopy is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026